Afya (AFYA) to Release Earnings on Thursday

Afya (NASDAQ:AFYA) is expected to post its quarterly earnings results before the market opens on Thursday, March 13th. Analysts expect Afya to post earnings of $0.36 per share and revenue of $848.25 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Afya Stock Down 0.9 %

Shares of AFYA opened at $16.97 on Tuesday. Afya has a 52-week low of $14.52 and a 52-week high of $22.24. The company has a market capitalization of $1.59 billion, a PE ratio of 13.69, a price-to-earnings-growth ratio of 0.29 and a beta of 0.82. The stock has a fifty day simple moving average of $16.35 and a two-hundred day simple moving average of $16.47. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.51.

Analyst Ratings Changes

AFYA has been the subject of a number of recent research reports. Citigroup reaffirmed a “sell” rating and issued a $15.00 target price (down from $18.00) on shares of Afya in a research note on Friday, January 31st. JPMorgan Chase & Co. cut their target price on Afya from $25.00 to $20.50 and set a “neutral” rating for the company in a research note on Friday, January 17th. Finally, The Goldman Sachs Group initiated coverage on Afya in a research note on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 target price for the company. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $18.00.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.